Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Behav Sleep Med. 2019 May 2;18(3):406–419. doi: 10.1080/15402002.2019.1604344

Table 4.

Logistic Regression Predicting Medication Adherence (at 12-month follow-up) from Sleep Quality Trajectory, N = 505

Medication Adherence
AOR p 95% CI
Constant 0.83 .56 [0.44, 1.55]
Age 1.00 .92 [0.98, 1.02]
Race and Ethnicity (ref. White)
 Black or Hispanic/Latino 0.79 .34 [0.49, 1.28]
Study Arm (ref. Control)
 Intervention 0.69 .12 [0.43, 1.10]
Relationship Status (ref. Single)
 Partnered 0.99 .98 [0.61, 1.62]
Viral Load at Screener (ref. Undetectable)
 Detectable (≥200 copies) 0.83 .60 [0.42, 1.65]
Education (ref. Less than college)
 College degree or more 1.47 .13 [0.89, 2.43]
Income (ref. less than $20K)
 $20K - $49,999 1.15 .63 [0.66, 2.01]
 $50K or more 1.12 .74 [0.58, 2.15]
SQ (ref. Good SQ, Maintained)
 Bad SQ, Improved 0.96 .90 [0.50, 1.82]
 Good SQ, Worsened 0.31 <.01 [0.13, 0.72]
 Bad SQ, Maintained 0.71 .23 [0.40, 1.25]
Adherence at Screener (ref. Suboptimal)
 Adherent (≥90% on Wilson) 7.16 <.001 [3.55, 14.44]
Model Statistics: Model χ2(12) = 58.58, p <.001
Percent correctly classified: 64.5%
Nagelkerke’s R2 = .20

Note. SQ = Sleep Quality; AOR = adjusted odds ratio; CI = confidence interval; ref. = referent.

Medication adherence assessed at study screening and 12-month follow-up using a 3-item self-report measure (Wilson et al., 2016).

Bolded results are significant at p <.05 or less.